Galderma Group AG (CHIX:GALDZ) Other Long-Term Liabilities : CHF408 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Long-Term Liabilities?

Galderma Group AG's other long-term liabilities for the quarter that ended in Dec. 2024 was CHF408 Mil.

Galderma Group AG's quarterly other long-term liabilities declined from Dec. 2023 (CHF401 Mil) to Jun. 2024 (CHF382 Mil) but then increased from Jun. 2024 (CHF382 Mil) to Dec. 2024 (CHF408 Mil).

Galderma Group AG's annual other long-term liabilities increased from . 20 (CHF0 Mil) to Dec. 2023 (CHF401 Mil) and increased from Dec. 2023 (CHF401 Mil) to Dec. 2024 (CHF408 Mil).

Galderma Group AG Other Long-Term Liabilities Historical Data

The historical data trend for Galderma Group AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Long-Term Liabilities Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Other Long-Term Liabilities

401.27

408.35

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Other Long-Term Liabilities	-	401.27	381.65	408.35

Galderma Group AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Galderma Group AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (CHIX:GALDz) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA PY3:Germany GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines